Atheromarkers of high-density lipoproteins. Part 1. High-density lipoproteins: Structure, composition, physicochemical and physiological antiatherogenic properties, their mechanisms and markers (a review of literature)

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Profilakticheskaya meditsina

• Publication date

  2017-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.17116/PROFMED201720347-54
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Density Lipoproteins : Multifunctional but Vulnerable Protections from Atherosclerosis

  2013cited by this paper
• Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis

  2013cited by this paper
• Characterization of Levels and Cellular Transfer of Circulating Lipoprotein-Bound MicroRNAs

  2013cited by this paper
• High-density lipoprotein subclasses and their relationship to cardiovascular disease.

  2012cited by this paper
• Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein

  2012cited by this paper
• Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.

  2012cited by this paper
• Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways.

  2012cited by this paper
• Predictive value of different HDL particles for the protection against or risk of coronary heart disease.

  2012cited by this paper
• HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.

  2011cited by this paper
• High-Density Lipoprotein: Is the Good Cholesterol Turning Bad?

  2011cited by this paper
• Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

  2011cited by this paper
• Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids.

  2011cited by this paper
• Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway

  2010cited by this paper
• Transintestinal cholesterol efflux.

  2010cited by this paper
• Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice*

  2010cited by this paper
• High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo

  2010cited by this paper
• Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma

  2010cited by this paper
• Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.

  2010cited by this paper
• Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function

  2009cited by this paper
• Stimulation of Cell Surface F1-ATPase Activity by Apolipoprotein A-I Inhibits Endothelial Cell Apoptosis and Promotes Proliferation

  2009cited by this paper
• Major lipids, apolipoproteins, and risk of vascular disease.

  2009cited by this paper
• The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.

  2009cited by this paper
• Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux

  2009cited by this paper
• RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes.

  2009cited by this paper
• High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response

  2008cited by this paper
• Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.

  2008cited by this paper
• High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells

  2008cited by this paper
• Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque

  2008cited by this paper
• Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes.

  2007cited by this paper
• Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

  2007cited by this paper
• Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities

  2007cited by this paper
• Role of Scavenger Receptor Class B Type I and Sphingosine 1-Phosphate Receptors in High Density Lipoprotein-induced Inhibition of Adhesion Molecule Expression in Endothelial Cells*

  2006cited by this paper
• High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells.

  2006cited by this paper
• High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor

  2006cited by this paper
• High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I

  2005cited by this paper
• High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component.

  2005cited by this paper
• HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

  2004cited by this paper
• ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.

  2004cited by this paper
• Restoration of Endothelial Function by Increasing High‐Density Lipoprotein in Subjects With Isolated Low High‐Density Lipoprotein

  2003cited by this paper
• Importance of different pathways of cellular cholesterol efflux.

  2003cited by this paper
• High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells.

  2003cited by this paper
• Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress

  2003cited by this paper
• Regulation of reverse cholesterol transport and clinical implications.

  2003cited by this paper
• High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men

  2002cited by this paper
• Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids*

  2001cited by this paper
• Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins.

  2001cited by this paper
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

  2001cited by this paper
• High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.

  2001cited by this paper
• Scavenger Receptor Class B, Type I-mediated [3H]Cholesterol Efflux to High and Low Density Lipoproteins Is Dependent on Lipoprotein Binding to the Receptor*

  2000cited by this paper
• High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced Apoptosis

  2000cited by this paper
• Regulatory effects of HDL on smooth muscle cell prostacyclin release.

  1999cited by this paper
• A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.

  1999cited by this paper
• Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells.

  1998cited by this paper
• HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate.

  1998cited by this paper
• HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL.

  1997cited by this paper
• HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2).

  1997cited by this paper
• Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux*

  1997cited by this paper
• High Density Lipoproteins Enhance the Na+/H+ Antiport in Human Platelets

  1996cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

  1995cited by this paper
• High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

  1995cited by this paper
• Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men.

  1995cited by this paper
• Comparative study of the activity and composition of HDL3 in Russian and American men.

  1993cited by this paper
• Formation of

  year unknowncited by this paper

• High-densitylipoprotein function in various pathological conditions

  2024cites this paper
• High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology

  2023cites this paper
• Functional diversity of high-density lipoproteins: finding the golden mean

  2021cites this paper